Filing Details
- Accession Number:
- 0001209191-15-070274
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-11 09:10:17
- Reporting Period:
- 2015-09-09
- Filing Date:
- 2015-09-11
- Accepted Time:
- 2015-09-11 09:10:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197023 | S Joshua Boger | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-09-09 | 10,400 | $35.64 | 355,684 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-09-09 | 800 | $130.02 | 354,884 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-09-09 | 8,000 | $131.29 | 346,884 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-09-09 | 1,100 | $132.35 | 345,784 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-09-09 | 500 | $133.41 | 345,284 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-09-09 | 10,400 | $0.00 | 10,400 | $35.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 208,800 | 2016-02-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,286 | Indirect | 401(k) |
| Common Stock | 122,700 | Indirect | Common Stock held in trust |
Footnotes
- Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
- Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $130.02 (range $129.78 to $130.68).
- Open market sales reported on this line occurred at a weighted average price of $131.29 (range $130.79 to $131.78).
- Open market sales reported on this line occurred at a weighted average price of $132.35 (range $132.06 to $132.52).
- Open market sales reported on this line occurred at a weighted average price of $133.41 (range $133.08 to $133.75).
- Fully vested.
Billionaire Hedge Funds
